Literature DB >> 17289880

Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer.

Ping-I Hsu1, Chung-Hsuan Chen, Chieu-Shia Hsieh, Wei-Chao Chang, Kwok-Hung Lai, Gin-Ho Lo, Ping-Ning Hsu, Feng-Woei Tsay, Yu-Shan Chen, Michael Hsiao, Hui-Chun Chen, Pei-Jung Lu.   

Abstract

PURPOSE: To search for novel disease-specific markers in gastric juice by investigating the protein concentrations and components in gastric juice from patients with various gastroduodenal diseases. EXPERIMENTAL
DESIGN: Protein concentrations and pH values in fasting gastric juice were examined in 120 healthy subjects and 39 gastric ulcer, 38 duodenal ulcer, and 31 gastric cancer patients. The protein components in gastric juice were studied by two-dimensional PAGE and mass spectrometric analysis.
RESULTS: Protein concentrations in gastric juice of patients with gastric ulcers and gastric cancer were significantly higher than those in healthy subjects (1.06 and 2.61 mg/mL versus 0.48 mg/mL; P=0.001 and P<0.001, respectively), and duodenal ulcer patients had lower gastric juice protein concentrations compared with healthy subjects (0.26 versus 0.48 mg/mL; P<0.05). Gastric hypoacidity and advanced age were independent factors affecting the protein concentrations in gastric juice with odds ratios of 32.9 (95% confidence interval, 11.8-90.9) and 3.2 (95% confidence interval, 1.3-8.3), respectively. Each electrophoresis images of gastric juice could be classified into one of three patterns: basic band, specific band, or nonspecific band. The frequencies of specific band pattern in healthy subjects, gastric ulcer, duodenal ulcer, and gastric cancer patients were 6%, 42%, 6%, and 93%, respectively. Proteomic analysis revealed that alpha1-antitrypsin precursor was the principal peptide in the specific band.
CONCLUSIONS: alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. A noninvasive method to obtain gastric juice followed by proteomic analysis may serve as a new tool to screen for gastric malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289880     DOI: 10.1158/1078-0432.CCR-06-1404

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 2.  Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.

Authors:  Lei Huang; Aman Xu
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  Proteomic analysis of endoscopically (endoscopic pancreatic function test) collected gastroduodenal fluid using in-gel tryptic digestion followed by LC-MS/MS.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Kathryn Repas; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  Proteomics Clin Appl       Date:  2010-09       Impact factor: 3.494

Review 4.  Biomedical applications of nanoflares: Targeted intracellular fluorescence probes.

Authors:  Karim Khanmohammadi Chenab; Reza Eivazzadeh-Keihan; Ali Maleki; Paria Pashazadeh-Panahi; Michael R Hamblin; Ahad Mokhtarzadeh
Journal:  Nanomedicine       Date:  2019-02-28       Impact factor: 5.307

5.  Gastric juice acidity in upper gastrointestinal diseases.

Authors:  Pei-Jung Lu; Ping-I Hsu; Chung-Hsuan Chen; Michael Hsiao; Wei-Chao Chang; Hui-Hwa Tseng; Kung-Hung Lin; Seng-Kee Chuah; Hui-Chun Chen
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

6.  Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures.

Authors:  Shahid Aziz; Faisal Rasheed; Rabaab Zahra; Simone König
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

7.  Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.

Authors:  N J Shimwell; D G Ward; Y Mohri; T Mohri; L Pallan; M Teng; Y C Miki; M Kusunoki; O Tucker; W Wei; J Morse; P J Johnson
Journal:  Br J Cancer       Date:  2012-09-11       Impact factor: 7.640

8.  Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.

Authors:  Luis Bujanda; Cristina Sarasqueta; Angel Cosme; Elizabeth Hijona; José M Enríquez-Navascués; Carlos Placer; Eloisa Villarreal; Marta Herreros-Villanueva; María D Giraldez; Meritxell Gironella; Francesc Balaguer; Antoni Castells
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

Review 9.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

10.  The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile.

Authors:  Oi Lian Kon; Tai-Tung Yip; Meng Fatt Ho; Weng Hoong Chan; Wai Keong Wong; Soo Yong Tan; Wai Har Ng; Siok Yuen Kam; Alvin Kh Eng; Patrick Ho; Rosa Viner; Hock Soo Ong; M Priyanthi Kumarasinghe
Journal:  BMC Med Genomics       Date:  2008-10-25       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.